Logo image of IPAR

INTERPARFUMS INC (IPAR) Stock Fundamental Analysis

NASDAQ:IPAR - Nasdaq - US4583341098 - Common Stock - Currency: USD

131.91  -0.82 (-0.62%)

After market: 131.91 0 (0%)

Fundamental Rating

6

Overall IPAR gets a fundamental rating of 6 out of 10. We evaluated IPAR against 35 industry peers in the Personal Care Products industry. IPAR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IPAR has a decent growth rate and is not valued too expensively. With these ratings, IPAR could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

IPAR had positive earnings in the past year.
In the past year IPAR had a positive cash flow from operations.
IPAR had positive earnings in each of the past 5 years.
IPAR had a positive operating cash flow in each of the past 5 years.
IPAR Yearly Net Income VS EBIT VS OCF VS FCFIPAR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

IPAR has a better Return On Assets (11.51%) than 80.00% of its industry peers.
With an excellent Return On Equity value of 21.02%, IPAR belongs to the best of the industry, outperforming 82.86% of the companies in the same industry.
The Return On Invested Capital of IPAR (18.91%) is better than 82.86% of its industry peers.
IPAR had an Average Return On Invested Capital over the past 3 years of 17.76%. This is above the industry average of 15.14%.
The 3 year average ROIC (17.76%) for IPAR is below the current ROIC(18.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.51%
ROE 21.02%
ROIC 18.91%
ROA(3y)10.68%
ROA(5y)8.79%
ROE(3y)21.16%
ROE(5y)17.18%
ROIC(3y)17.76%
ROIC(5y)14.62%
IPAR Yearly ROA, ROE, ROICIPAR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 11.30%, IPAR belongs to the top of the industry, outperforming 88.57% of the companies in the same industry.
In the last couple of years the Profit Margin of IPAR has grown nicely.
With an excellent Operating Margin value of 19.49%, IPAR belongs to the best of the industry, outperforming 91.43% of the companies in the same industry.
In the last couple of years the Operating Margin of IPAR has grown nicely.
IPAR has a Gross Margin (56.04%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of IPAR has remained more or less at the same level.
Industry RankSector Rank
OM 19.49%
PM (TTM) 11.3%
GM 56.04%
OM growth 3Y3.91%
OM growth 5Y5.52%
PM growth 3Y4.43%
PM growth 5Y6.05%
GM growth 3Y0.16%
GM growth 5Y0.24%
IPAR Yearly Profit, Operating, Gross MarginsIPAR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IPAR is creating value.
The number of shares outstanding for IPAR has been increased compared to 1 year ago.
IPAR has more shares outstanding than it did 5 years ago.
IPAR has a better debt/assets ratio than last year.
IPAR Yearly Shares OutstandingIPAR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
IPAR Yearly Total Debt VS Total AssetsIPAR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

IPAR has an Altman-Z score of 6.84. This indicates that IPAR is financially healthy and has little risk of bankruptcy at the moment.
IPAR's Altman-Z score of 6.84 is amongst the best of the industry. IPAR outperforms 82.86% of its industry peers.
IPAR has a debt to FCF ratio of 0.85. This is a very positive value and a sign of high solvency as it would only need 0.85 years to pay back of all of its debts.
IPAR has a better Debt to FCF ratio (0.85) than 82.86% of its industry peers.
IPAR has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
IPAR has a Debt to Equity ratio of 0.15. This is comparable to the rest of the industry: IPAR outperforms 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.85
Altman-Z 6.84
ROIC/WACC2.17
WACC8.73%
IPAR Yearly LT Debt VS Equity VS FCFIPAR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IPAR has a Current Ratio of 2.97. This indicates that IPAR is financially healthy and has no problem in meeting its short term obligations.
IPAR's Current ratio of 2.97 is fine compared to the rest of the industry. IPAR outperforms 74.29% of its industry peers.
A Quick Ratio of 1.68 indicates that IPAR should not have too much problems paying its short term obligations.
IPAR has a Quick ratio of 1.68. This is in the better half of the industry: IPAR outperforms 71.43% of its industry peers.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 1.68
IPAR Yearly Current Assets VS Current LiabilitesIPAR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.43% over the past year.
Measured over the past years, IPAR shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.27% on average per year.
Looking at the last year, IPAR shows a quite strong growth in Revenue. The Revenue has grown by 10.32% in the last year.
IPAR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 15.27% yearly.
EPS 1Y (TTM)21.43%
EPS 3Y22.78%
EPS 5Y22.27%
EPS Q2Q%3.94%
Revenue 1Y (TTM)10.32%
Revenue growth 3Y18.2%
Revenue growth 5Y15.27%
Sales Q2Q%4.59%

3.2 Future

The Earnings Per Share is expected to grow by 5.80% on average over the next years.
Based on estimates for the next years, IPAR will show a small growth in Revenue. The Revenue will grow by 4.56% on average per year.
EPS Next Y5.32%
EPS Next 2Y6.82%
EPS Next 3Y5.8%
EPS Next 5YN/A
Revenue Next Year3.78%
Revenue Next 2Y3.51%
Revenue Next 3Y4.56%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IPAR Yearly Revenue VS EstimatesIPAR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
IPAR Yearly EPS VS EstimatesIPAR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 25.03, IPAR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of IPAR is on the same level as its industry peers.
When comparing the Price/Earnings ratio of IPAR to the average of the S&P500 Index (26.98), we can say IPAR is valued inline with the index average.
Based on the Price/Forward Earnings ratio of 22.14, the valuation of IPAR can be described as rather expensive.
Based on the Price/Forward Earnings ratio, IPAR is valued a bit cheaper than 62.86% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IPAR to the average of the S&P500 Index (21.49), we can say IPAR is valued inline with the index average.
Industry RankSector Rank
PE 25.03
Fwd PE 22.14
IPAR Price Earnings VS Forward Price EarningsIPAR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

IPAR's Enterprise Value to EBITDA is on the same level as the industry average.
IPAR's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IPAR is cheaper than 68.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.62
EV/EBITDA 13.18
IPAR Per share dataIPAR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of IPAR may justify a higher PE ratio.
PEG (NY)4.7
PEG (5Y)1.12
EPS Next 2Y6.82%
EPS Next 3Y5.8%

5

5. Dividend

5.1 Amount

IPAR has a Yearly Dividend Yield of 2.41%.
IPAR's Dividend Yield is a higher than the industry average which is at 5.83.
Compared to an average S&P500 Dividend Yield of 2.42, IPAR has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.41%

5.2 History

On average, the dividend of IPAR grows each year by 22.18%, which is quite nice.
IPAR has been paying a dividend for at least 10 years, so it has a reliable track record.
IPAR has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)22.18%
Div Incr Years4
Div Non Decr Years4
IPAR Yearly Dividends per shareIPAR Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

IPAR pays out 58.92% of its income as dividend. This is a bit on the high side, but may be sustainable.
The dividend of IPAR is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP58.92%
EPS Next 2Y6.82%
EPS Next 3Y5.8%
IPAR Yearly Income VS Free CF VS DividendIPAR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M
IPAR Dividend Payout.IPAR Dividend Payout, showing the Payout Ratio.IPAR Dividend Payout.PayoutRetained Earnings

INTERPARFUMS INC

NASDAQ:IPAR (6/27/2025, 8:23:33 PM)

After market: 131.91 0 (0%)

131.91

-0.82 (-0.62%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners62.08%
Inst Owner Change2.89%
Ins Owners43.6%
Ins Owner Change5.73%
Market Cap4.24B
Analysts84.44
Price Target168.3 (27.59%)
Short Float %6.66%
Short Ratio4.84
Dividend
Industry RankSector Rank
Dividend Yield 2.41%
Yearly Dividend3
Dividend Growth(5Y)22.18%
DP58.92%
Div Incr Years4
Div Non Decr Years4
Ex-Date06-13 2025-06-13 (0.8)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.03%
Min EPS beat(2)8.41%
Max EPS beat(2)17.65%
EPS beat(4)4
Avg EPS beat(4)9%
Min EPS beat(4)3.48%
Max EPS beat(4)17.65%
EPS beat(8)6
Avg EPS beat(8)6.94%
EPS beat(12)10
Avg EPS beat(12)14.91%
EPS beat(16)14
Avg EPS beat(16)26.1%
Revenue beat(2)0
Avg Revenue beat(2)-1.3%
Min Revenue beat(2)-2%
Max Revenue beat(2)-0.59%
Revenue beat(4)0
Avg Revenue beat(4)-1.44%
Min Revenue beat(4)-2.03%
Max Revenue beat(4)-0.59%
Revenue beat(8)2
Avg Revenue beat(8)-0.19%
Revenue beat(12)4
Avg Revenue beat(12)0.36%
Revenue beat(16)5
Avg Revenue beat(16)0.05%
PT rev (1m)1.85%
PT rev (3m)-2.51%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.81%
EPS NY rev (1m)0.75%
EPS NY rev (3m)0.75%
Revenue NQ rev (1m)0.77%
Revenue NQ rev (3m)0.52%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.13%
Valuation
Industry RankSector Rank
PE 25.03
Fwd PE 22.14
P/S 2.89
P/FCF 22.62
P/OCF 18.24
P/B 5.37
P/tB 8.89
EV/EBITDA 13.18
EPS(TTM)5.27
EY4%
EPS(NY)5.96
Fwd EY4.52%
FCF(TTM)5.83
FCFY4.42%
OCF(TTM)7.23
OCFY5.48%
SpS45.68
BVpS24.55
TBVpS14.83
PEG (NY)4.7
PEG (5Y)1.12
Profitability
Industry RankSector Rank
ROA 11.51%
ROE 21.02%
ROCE 25.21%
ROIC 18.91%
ROICexc 22.26%
ROICexgc 32.84%
OM 19.49%
PM (TTM) 11.3%
GM 56.04%
FCFM 12.77%
ROA(3y)10.68%
ROA(5y)8.79%
ROE(3y)21.16%
ROE(5y)17.18%
ROIC(3y)17.76%
ROIC(5y)14.62%
ROICexc(3y)22.72%
ROICexc(5y)19.96%
ROICexgc(3y)35.6%
ROICexgc(5y)32.29%
ROCE(3y)23.62%
ROCE(5y)19.43%
ROICexcg growth 3Y6.05%
ROICexcg growth 5Y-2.44%
ROICexc growth 3Y8.08%
ROICexc growth 5Y4.09%
OM growth 3Y3.91%
OM growth 5Y5.52%
PM growth 3Y4.43%
PM growth 5Y6.05%
GM growth 3Y0.16%
GM growth 5Y0.24%
F-Score8
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF 0.85
Debt/EBITDA 0.37
Cap/Depr 158.92%
Cap/Sales 3.06%
Interest Coverage 36.8
Cash Conversion 73.92%
Profit Quality 112.98%
Current Ratio 2.97
Quick Ratio 1.68
Altman-Z 6.84
F-Score8
WACC8.73%
ROIC/WACC2.17
Cap/Depr(3y)438.01%
Cap/Depr(5y)567.12%
Cap/Sales(3y)5.93%
Cap/Sales(5y)7.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.43%
EPS 3Y22.78%
EPS 5Y22.27%
EPS Q2Q%3.94%
EPS Next Y5.32%
EPS Next 2Y6.82%
EPS Next 3Y5.8%
EPS Next 5YN/A
Revenue 1Y (TTM)10.32%
Revenue growth 3Y18.2%
Revenue growth 5Y15.27%
Sales Q2Q%4.59%
Revenue Next Year3.78%
Revenue Next 2Y3.51%
Revenue Next 3Y4.56%
Revenue Next 5YN/A
EBIT growth 1Y24.82%
EBIT growth 3Y22.82%
EBIT growth 5Y21.64%
EBIT Next Year12.21%
EBIT Next 3Y7.7%
EBIT Next 5YN/A
FCF growth 1Y1773.21%
FCF growth 3YN/A
FCF growth 5Y20.52%
OCF growth 1Y76.34%
OCF growth 3Y16.2%
OCF growth 5Y19.66%